首页> 美国卫生研究院文献>Journal of Diabetes Science and Technology >Analysis of an Electrochemical Blood Glucose Monitoring System with Hematocrit Compensation: Improved Accuracy by Design
【2h】

Analysis of an Electrochemical Blood Glucose Monitoring System with Hematocrit Compensation: Improved Accuracy by Design

机译:具有血细胞比容补偿的电化学血糖监测系统的分析:通过设计提高了准确性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The article entitled “Hematocrit Compensation in Electrochemical Blood Glucose Monitoring Systems” by Teodorczyk and colleagues in this issue of Journal of Diabetes Science and Technology demonstrates that the OneTouch® Verio™ glucose meter meets current regulatory expectations for glucose meter performance and is relatively free from interference by hematocrit. The lack of influence of hematocrit on whole blood glucose results is a valuable attribute for hospital applications, where greater variation of hematocrit among patients is anticipated. The choice of reference method for evaluation of glucose meters is an important consideration, and it is not clear to what extent reference methods used to evaluate glucose meters are also free from hematocrit interferences.
机译:Teodorczyk及其同事在本期《糖尿病科学与技术》上发表的题为“电化学血糖监测系统中的血细胞比容补偿”的文章证明,OneTouch ® Verio™血糖仪符合当前对血糖仪的监管要求性能,相对不受血细胞比容的干扰。血细胞比容缺乏对全血糖结果的影响是医院应用的重要属性,在医院应用中,预期患者之间血细胞比容的更大变化。选择用于评估血糖仪的参考方法是一个重要的考虑因素,目前尚不清楚用于评估血糖仪的参考方法在多大程度上也不受血细胞比容的干扰。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号